ATC
IONS icon

Argent Trust Co’s Ionis Pharmaceuticals IONS Stock Holding History

Argent Trust Co’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$227K Hold
3,018
– – 0.01% 670
2025
Q4 		$239K Buy
+3,018
New +$227K 0.01% 642
2021
Q2 		– Sell
-5,736
Closed -$258K – 513
2021
Q1 		$258K Buy
+5,736
New +$320K 0.02% 443

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Argent Trust Co's IONS Position: Q1 2026 in Review

Argent Trust Co held its Ionis Pharmaceuticals (IONS) position steady in Q1 2026 at 3,018 shares worth $227K. The position accounts for 0.01% of the portfolio, ranked #670.

Argent Trust Co first reported a position in IONS in Q1 2021 and has held it in 3 quarters since. The position peaked at $258K in Q1 2021. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Argent Trust Co held 3,018 shares of Ionis Pharmaceuticals worth $227K as of Q1 2026.
  • Argent Trust Co left its Ionis Pharmaceuticals share count unchanged in Q1 2026.
  • Ionis Pharmaceuticals made up 0.01% of Argent Trust Co's portfolio in Q1 2026, its #670 holding.
  • Argent Trust Co first reported a position in Ionis Pharmaceuticals in Q1 2021 and has held it in 3 quarters since.
  • Argent Trust Co's Ionis Pharmaceuticals position peaked at $258K in Q1 2021.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Argent Trust Co's 13F filing for Q1 2026, filed 13 May 2026.